Cover Image

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells

Saved in:

Bibliographic Details
Main Authors:	Xu Wang (Author), Renjie Hui (Author), Yun Chen (Author), Wentao Wang (Author), Yujiao Chen (Author), Xiaohai Gong (Author), Jian Jin (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
by: Xu Wang, et al.
Published: (2019)

Hesperidin increase cytotoxic effect of doxorubicin in MCF-7 cells
by: Adam Hermawan, et al.
Published: (2010)

Corrigendum: Furanodiene Induces Extrinsic and Intrinsic Apoptosis in Doxorubicin-Resistant MCF-7 Breast Cancer Cells via NF-κB-Independent Mechanism
by: Zhang-Feng Zhong, et al.
Published: (2017)

The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
by: Riris Istighfari Jenie, et al.
Published: (2018)

A novel agent enhances the chemotherapeutic efficacy of doxorubicin in MCF-7 breast cancer cells
by: Liang Wang, et al.
Published: (2016)

Furanodiene Induces Extrinsic and Intrinsic Apoptosis in Doxorubicin-Resistant MCF-7 Breast Cancer Cells via NF-κB-Independent Mechanism
by: Zhang-Feng Zhong, et al.
Published: (2017)

A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression
by: Ting Wang, et al.
Published: (2021)

Doxorubicin-conjugated dexamethasone induced MCF-7 apoptosis without entering the nucleus and able to overcome MDR-1-induced resistance
by: Chaikomon K, et al.
Published: (2018)

INCREASING SENSITIVITY OF MCF-7/DOX CELLS TOWARDS DOXORUBICIN BY HESPERETIN THROUGH SUPPRESSION OF P-GLYCOPROTEIN EXPRESSION
by: Sarmoko, et al.
Published: (2014)

n-Butanolic fraction of endofitic fungi of Buah Makasar increases apoptotic effect of doxorubicin on MCF-7 cells
by: Edy Meiyanto, et al.
Published: (2009)

Preparation and evaluation of poly(l-histidine) based pH-sensitive micelles for intracellular delivery of doxorubicin against MCF-7/ADR cells
by: Nan Jia, et al.
Published: (2017)

Differential Expression of HSP90β in MDA-MB-231 and MCF-7 Cell Lines after Treatment with Doxorubicin
by: Fereshte Jokar, et al.
Published: (2019)

Combination effect of doxorubicin and HIF inhibitor on MCF-7 CD44+/CD24- subpopulation cells in hypoxic condition
by: Azadeh Rasouli, et al.
Published: (2022)

Evaluation of anti-proliferative activity of simvastatin and atorvastatin on MCF7 cell line compared with doxorubicin using MTT test
by: Aiyat Hasan Yahya Al-khafaji, et al.
Published: (2018)

Actions of sesquiterpene lactones isolated from Moquiniastrum polymorphum subsp. floccosum in MCF7 cell line and their potentiating action on doxorubicin
by: Mariana de Oliveira Mauro, et al.
Published: (2017)

Hippuric acid nanocomposite enhances doxorubicin and oxaliplatin-induced cytotoxicity in MDA-MB231, MCF-7 and Caco2 cell lines
by: Hussein Al Ali SH, et al.
Published: (2013)

Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
by: Sepideh Mirzaei, et al.
Published: (2021)

Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids
by: Supusson Pengnam, et al.
Published: (2021)

The Impact of Fullerenes as Doxorubicin Nano-Transporters on Metallothionein and Superoxide Dismutase Status in MCF-10A Cells
by: Natalia Zaręba, et al.
Published: (2022)

Computational approach to the design of hyaluronic acid copolymer based doxorubicin micelles
by: Yujiao Sun, et al.
Published: (2016)

Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
by: Zar Chi Soe, et al.
Published: (2019)

Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance
by: Zhenzhen Chen, et al.
Published: (2023)

Human Growth Hormone Fragment 176–191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells
by: Habibullah MM, et al.
Published: (2022)

Quantitative determination of doxorubicin in the exosomes of A549/MCF-7 cancer cells and human plasma using ultra performance liquid chromatography-tandem mass spectrometry
by: Mohammad H. Semreen, et al.
Published: (2018)

Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
by: Harahap Y, et al.
Published: (2020)

Doxorubicin: The dogma and the bone
by: Jia Y. Wong, et al.
Published: (2016)

Local penetration of doxorubicin via intrahepatic implantation of PLGA based doxorubicin-loaded implants
by: Li Gao, et al.
Published: (2019)

Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy
by: Mingming Song, et al.
Published: (2021)

Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells
by: Zhangfeng Zhong, et al.
Published: (2018)

Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
by: Baozhen Zhang, et al.
Published: (2018)

Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975]
by: Gamal Eldein Fathy Abd-ellatef, et al.
Published: (2023)

Protective Effect of Omega-7 against Doxorubicin-Induced Cardiotoxicity in Male Rats
by: Mohammed H. Fadhel, et al.
Published: (2023)

Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression
by: Jiayi Chen, et al.
Published: (2021)

Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
by: Xiaoxiao Lin, et al.
Published: (2023)

Doxorubicin-induced ovarian toxicity
by: Rizel Shulamith, et al.
Published: (2010)

The Roles of Doxorubicin in Hepatocellular Carcinoma
by: Kin Tam
Published: (2013)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023)

Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
by: Shuhui Zhang, et al.
Published: (2020)

A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID
by: Yun-chao Xu, et al.
Published: (2018)

Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
by: Hai-Bo Zhang, et al.
Published: (2023)